Ευρωπαϊκή Ένωση - Ισλανδικά - EMA (European Medicines Agency)

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - sykursýki, tegund 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - quetiapinum fúmarat - forðatafla - 300 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - quetiapinum fúmarat - forðatafla - 150 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - quetiapinum fúmarat - forðatafla - 50 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - quetiapinum fúmarat - forðatafla - 200 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - quetiapinum fúmarat - forðatafla - 400 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - candesartanum cílexetíl - tafla - 8 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - candesartanum cílexetíl - tafla - 16 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - candesartanum cílexetíl - tafla - 32 mg

Ευρωπαϊκή Ένωση - Ισλανδικά - EMA (European Medicines Agency)

pharmathen s.a. - ibandrónsýra - hypercalcemia; fractures, bone; neoplasm metastasis; breast neoplasms - lyf til að meðhöndla beinsjúkdóma - concentrate for solution for infusion prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases. meðferð æxli völdum álíka með eða án meinvörp. film-coated tablets prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.